LJPC) has been on a tear over the past year. Now it is looking to capitalize on its increased price and raise more capital. The company announced the pricing of an underwritten offering of 2.55 million shares of its common stock at $38.00 per …
SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the “Company” or “La Jolla”), a …
La Jolla Pharmaceutical Company (LJPC) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at LJPC given that, …
ETRM closed Monday's trading at $1.94, up 1.57%. In after-hours, the stock gained another 7.73% to $2.09. La Jolla Pharmaceutical Co.'s (LJPC) New Drug Application for LJPC-501 for the treatment of hypotension in adults with …
La Jolla Pharmaceutical Company (NASDAQ: LJPC) announced that it has called a ... available for distribution to holders of the approximately 66M shares of common stock issued and outstanding.
La Jolla Pharmaceutical Co. (NASDAQ: LJPC) has seen its shares jump on this wave with an ... in a 52-week trading range of $6.17 to $24.89. The stock has a consensus analyst price target of $36.20.
MakeMyTrip Limited (Nasdaq: MMYT) filed a registration statement with the U.S. Securities and Exchange Commission today for an Initial Public Offering of its common stock. The proposed maximum aggregate offering price is $100 million. …
SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (OTCBB:LJPC), a biopharmaceutical company dedicated to improving and preserving human life by acquiring and developing innovative pharmaceutical products, …
GenMark Diagnostics, Inc. (NASDAQ: GNMK) filed a registration statement with the U.S. Securities and Exchange Commission for an initial public offering of its common stock. The proposed maximum aggregate offering price is $46 …